Innovative biological product approvals (half year)
RecordSTO-68SAW6G0Z4-YJH1MEHPZT-9TADHJ
China · January–June 2026
Innovative biological product approvals in China (half year) were 17 in January–June 2026 (NHSA).
New drug approvals in China: every year, the rank and how it is measured
- Publisher
- NHSA
- Authority tier
- T1 Official
- Report
- 我国上半年创新药对外授权交易额超千亿美元
- Locator
- 今年38个1类创新药已获批上市 11款新靶点、新机制药均为国产
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
国家药监局药品注册管理司副司长蓝恭涛表示，截至6月底，国家药监局今年共批准药品上市注册申请2318件，其中“全球新”创新药38个，包括20个化学药品，17个生物制品和1个中药。
Checked: the figure 17is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
National Healthcare Security Administration. (2026). 我国上半年创新药对外授权交易额超千亿美元. Retrieved September 17, 2026, from http://www.nhsa.gov.cn/art/2026/7/14/art_14_21423.html. Via StatOrigin, https://statorigin.org/stat/stat_68SAW6G0Z4YJH1MEHPZT9TADHJ
Other formats: MLA, Chicago, BibTeX
- MLA
- National Healthcare Security Administration. "我国上半年创新药对外授权交易额超千亿美元." 2026, http://www.nhsa.gov.cn/art/2026/7/14/art_14_21423.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_68SAW6G0Z4YJH1MEHPZT9TADHJ.
- Chicago
- National Healthcare Security Administration. "我国上半年创新药对外授权交易额超千亿美元." 2026. http://www.nhsa.gov.cn/art/2026/7/14/art_14_21423.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_68SAW6G0Z4YJH1MEHPZT9TADHJ.
- BibTeX
- @misc{nhsa2026innovative9tadhj, author = {{National Healthcare Security Administration}}, title = {我国上半年创新药对外授权交易额超千亿美元}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_68SAW6G0Z4YJH1MEHPZT9TADHJ}, note = {Original source: http://www.nhsa.gov.cn/art/2026/7/14/art\_14\_21423.html. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- National Healthcare Security Administration · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- 我国上半年创新药对外授权交易额超千亿美元
- Type
- Press release
- Published
- —
- Locator
- 今年38个1类创新药已获批上市 11款新靶点、新机制药均为国产
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 26 September 2026
- Permanent URL
- /stat/stat_68SAW6G0Z4YJH1MEHPZT9TADHJ